Share Name Share Symbol Market Type Share ISIN Share Description
Horizon Discvry LSE:HZD London Ordinary Share GB00BK8FL363 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -5.00p -3.64% 132.50p 130.00p 135.00p 137.50p 132.50p 137.50p 1,508,463 14:00:00
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Health Care Equipment & Services 20.2 -10.5 -11.2 - 126.04

Horizon Discvry (HZD) Latest News

More Horizon Discvry News
Horizon Discvry Takeover Rumours

Horizon Discvry (HZD) Share Charts

1 Year Horizon Discvry Chart

1 Year Horizon Discvry Chart

1 Month Horizon Discvry Chart

1 Month Horizon Discvry Chart

Intraday Horizon Discvry Chart

Intraday Horizon Discvry Chart

Horizon Discvry (HZD) Discussions and Chat

Horizon Discvry Forums and Chat

Date Time Title Posts
20/10/201615:13Horizon Discovery Ltd - Genomic translation 530
23/7/201415:43Alan Green says to BUY and HOLD in Horizon-

Add a New Thread

Horizon Discvry (HZD) Most Recent Trades

Trade Time Trade Price Trade Size Trade Value Trade Type
View all Horizon Discvry trades in real-time

Horizon Discvry (HZD) Top Chat Posts

Horizon Discvry Daily Update: Horizon Discvry is listed in the Health Care Equipment & Services sector of the London Stock Exchange with ticker HZD. The last closing price for Horizon Discvry was 137.50p.
Horizon Discvry has a 4 week average price of 146.80p and a 12 week average price of 155.58p.
The 1 year high share price is 187p while the 1 year low share price is currently 125p.
There are currently 95,122,660 shares in issue and the average daily traded volume is 102,148 shares. The market capitalisation of Horizon Discvry is £126,037,524.50.
kestelmill: Yes, amazing how people get into a panic as the share price is going down and there hasn't been any news for 5 mins. What's important is that the fundamentals are there, i.e. good demand being met at a good gross margin, a strong competitive advantage and barriers to entry. I will also be adding at this price and hopefully even lower. The only concern for me is that the services revenues have stalled. I wasn't expecting this. However, the products revenues is increasing very nicely. The other thing to point out is that the CEO is clearly highly entrepreneurial and starting lots of different projects, only some of which will be successful. At this stage of a business there is likely to be fat and unprofitable areas in the business as they give things a go and see what works. In 5 years time they may have a different CEO or perhaps Private Equity buy-out which will focus in and strip out any excess.
pjj71: del, 'whats not to like?' - the current share price collapse! - hopefully it will head up again soon!!!
deltrotter: Nice buy point melody. I am a 'fan' of this company. I am a LTBH investor, so I am looking 5 years out for the BIG returns, but I would expect to see the share price start to pick up substantially next year as profit starts to come over the horizon (sorry for the pun).
nurdin: 'Horizon Discovery Group PLC with EPIC/TICKER LON:HZD has had its stock rating noted as ‘Retains’; with the recommendation being set at ‘BUY’ this morning by analysts at Panmure Gordon. Horizon Discovery Group PLC are listed in the Health Care sector within AIM. Panmure Gordon have set a target price of 270 GBX on its stock. This would indicate that the analyst believes there is a potential upside of 62.7% from the opening price of 166 GBX. Over the last 30 and 90 trading days the company share price has increased 13 points and increased 15.25 points respectively.' Nice.
deltrotter: Today's daily mail On the alternative market, life sciences company Horizon Discovery revealed two agreements with an undisclosed provider of ‘market leading next- generation sequencing’, which is a rapidly growing area of cancer treatment. It’s concerned with editing your genes so your body can recognise abnormal cells. Horizon is providing a reference standard, which is basically a benchmark or toolkit for firms which make the tests that diagnose diseases such as cancer. Horizon’s toolkit lets labs check their tests are working. It has not disclosed the finances of the deal or who it is with – although some experts believe it is with Illumina, a market leader in the field. Analysts at Numis were positive on the news, because as this type of treatment becomes more accurate and affordable, the broker said up to 30 per cent of the millions of people across the world who are diagnosed with cancer could be treated in this way. Horizon’s share price gained 1.5 per cent, or 2.5p, to 172.5p. Read more: Follow us: @MailOnline on Twitter | DailyMail on Facebook
kestelmill: thank you for posting the presentation. I watched the whole thing and I thought he explained very simply and clearly; even I could understand it. Very interesting insights. -AAV has advantages over CRISPr and only Horizon can do AAV -R&D people would rather buy ready-made edited cells than do it themselves (quicker, cheaper) -Vending machine model -Haplogen acquisition gave high throughput system for gene editing -Market has been flooded with shares due to acquisitions which may have driven down share price
mirabeau: I must admit to pangs of guilt for setting this thread up when one considers the poor price performance. I hope no one's lost significant monies. Anyway, this is from today's DM and reveals HZD's promising future. Good fortune holders --- 'UP from a January low of 125p, shares of Horizon Discovery advanced 6.5p to 148p after Panmure Gordon’s analyst Mike Mitchell advised clients that its technology platform and strategic positioning makes the business one of the most interesting UK-quoted life sciences companies in the market. The strategic positioning of the company is unparalleled and the current share price is a compelling entry point for investors. January 2015’s high was 237p.' HTTP://
mamcw: Some fairly chunky volume today - hopefully the beginning of the end to a miserable share price performance over the last 6 months.
oggyrocks: Share price looking good. Buying on the bid. Expect to see it rise again on further buying. Chart looking good. All positives here. Only a smallish holding for me, but think it will be a profitable next future.
oggyrocks: Looks fantastic RNS today. Hopefully this should mark a turning point in the share price. Or maybe stop the seller from selling. Great to be involved in such an exciting and progressive company. Not a massive holding for me, but hopefully this could eventually be a v profitable one.
Horizon Discvry share price data is direct from the London Stock Exchange
Your Recent History
Gulf Keyst..
FTSE 100
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:43 V: D:20161020 19:41:39